Clinical Trial Update: Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial [Phase 2]

View source ↗

Summary

Ongoing Phase 2 pilot clinical trial evaluating riluzole to prevent cognitive dysfunction in cancer patients undergoing chemotherapy, with multiple cancer indic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Gastric Cancer
• Head and Neck Cancer
• Liver Cancer
• Lung Cancer
• Ovarian Cancer
• Sarcoma

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: University of California, Irvine | Conditions: Breast Cancer, Sarcoma | Phase 2 | Status: RECRUITING